Kerry A. Casey

Progenics Pharmaceuticals (United States)

Also affiliated with AstraZeneca (Brazil), AstraZeneca (Germany)

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus”.

Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus

Arthritis & Rheumatology(2020)10.1002/art.41518

N/A

1.9DataRank · unranked

74 citations

Michael A. Smith, Dominic Sinibaldi, Nickie Seto, Martin P. Playford, Xinghao Wang +10 more

Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile Dermatomyositis

Arthritis & Rheumatology(2023)10.1002/art.42615

N/A

0.728DataRank · unranked

19 citations

Mythri Ambatipudi, Terrance P. OʼHanlon, Michael A. Smith, Melissa de los Reyes, Adam Schiffenbauer +8 more

Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositis

Arthritis Research & Therapy(2024)10.1186/s13075-024-03421-7

N/A

0DataRank · unranked

2 citations

James M. Ward, Kakali Sarkar, Adam Schiffenbauer, Payam Noroozi Farhadi, Michael A. Smith +7 more